Showing results (401-410 of 421) with videos related to

Sort By:
Pageof 43
Frontiers in Immunology|September 13, 2023
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologicsMargaux Lelong, Régis Josien, Marianne Coste-Burel, et al.
Nature Genetics|May 15, 2007
Variation in FTO contributes to childhood obesity and severe adult obesityChristian Dina, David Meyre, Sophie Gallina, et al.
RMD Open|March 15, 2024
Concordance and agreement between different activity scores in polymyalgia rheumaticaJustine D'Agostino, Aghiles Souki, Anne Lohse, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2025
Maintenance of remission after tocilizumab withdrawal in patients with glucocorticoid-dependent polymyalgia rheumaticaBaptiste Chevet, Aghiles Souki, Emmanuel Nowak, et al.
Journal of Crohn'S & Colitis|September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAIDPauline Wils, Romain Altwegg, Anthony Buisson, et al.
Alimentary Pharmacology & Therapeutics|May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre StudyMathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Scientific Reports|December 11, 2020
Analysis of enteric nervous system and intestinal epithelial barrier to predict complications in Hirschsprung's diseaseAnne Dariel, Lucie Grynberg, Marie Auger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID StudyMathurin Fumery, Benedicte Caron, Xavier Hébuterne, et al.
Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitisSailish Honap, Joelle St-Pierre, Michael Colwill, et al.
Pageof 43